Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors

Por Wakelee, H. A., Patnaik, A., Sikic, B. I., Mita, M., Fox, N. L., Miceli, R., Ullrich, S. J., Fisher, G. A., Tolcher, A. W.
Publicado em 2010

Differential effect of age on survival in advanced NSCLC in women versus men: Analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab

Por Wakelee, H.A., Dahlberg, S.E., Brahmer, J.R., Schiller, J.H., Perry, M.C., Langer, C.J., Sandler, A.B., Belani, C.P., Johnson, D.H.
Publicado em 2012

A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell l...

Por Chen, H, Modiano, M R, Neal, J W, Brahmer, J R, Rigas, J R, Jotte, R M, Leighl, N B, Riess, J W, Kuo, C J, Liu, L, Gao, B, DiCioccio, A T, Adjei, A A, Wakelee, H A
Publicado em 2014

Active and passive smoking in relation to lung cancer incidence in the Women's Health Initiative Observational Study prospective cohort(†)

Por Wang, A., Kubo, J., Luo, J., Desai, M., Hedlin, H., Henderson, M., Chlebowski, R., Tindle, H., Chen, C., Gomez, S., Manson, J. E., Schwartz, A. G., Wactawski-Wende, J., Cote, M., Patel, M. I., Stefanick, M. L., Wakelee, H. A.
Publicado no Ann Oncol (2015)

A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours

Por Diaz-Padilla, I, Siu, L L, San Pedro-Salcedo, M, Razak, A R A, Colevas, A D, Shepherd, F A, Leighl, N B, Neal, J W, Thibault, A, Liu, L, Lisano, J, Gao, B, Lawson, E B, Wakelee, H A
Publicado em 2012

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma

Por Krug, A K, Enderle, D, Karlovich, C, Priewasser, T, Bentink, S, Spiel, A, Brinkmann, K, Emenegger, J, Grimm, D G, Castellanos-Rizaldos, E, Goldman, J W, Sequist, L V, Soria, J -C, Camidge, D R, Gadgeel, S M, Wakelee, H A, Raponi, M, Noerholm, M, Skog, J
Publicado no Ann Oncol (2018)